<DOC>
	<DOCNO>NCT02975219</DOCNO>
	<brief_summary>Incomplete resection endometriosis lesion often result recurrence symptom need repeat surgery , considerable associate morbidity . The aim pilot project determine feasibility fluorescence image improve treatment endometriosis future .</brief_summary>
	<brief_title>Feasibility Study Using Molecular Fluorescence Guided Surgery Endometriosis</brief_title>
	<detailed_description />
	<mesh_term>Endometriosis</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<criteria>1 . Females age â‰¥ 18 year 2 . Scheduled surgery treatment endometriosis 3. WHO performance score 02 4 . Written inform consent For female subject childbearing potential , premenopausal intact reproductive organ le 2 year postmenopausal : 5 . A negative serum pregnancy test prior receive tracer 6 . Willing ensure partner us effective contraception trial 6 month thereafter . 1 . Medical psychiatric condition compromise patient 's ability give inform consent 2 . Pregnancy 3 . History infusion reaction Bevacizumab monoclonal antibody therapies 4 . Significant renal , cardiac , pulmonary disease ( ASA IIIIV )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>